for Jan 19, 2021
Reducing unnecessary antibiotic prescriptions in #COVID19 remains a challenge. Our paper tackling this finally out in @BSACandJAC!
— Gabriele Pollara (@gpollara) January 19, 2021
Routinely measured inflammatory markers can help exclude bacterial co-infection & promote #antimicrobialstewardship
(1/5)https://t.co/lSBq5pU2lY pic.twitter.com/xSrBeaZL5O
Rochelle Walensky: new Director of the US CDC https://t.co/L8U1mPBIIF. Couldn’t be more thrilled that @RWalensky will be the new @CDCgov Director. She will be transformative and under her leadership the agency will regain its credibility and trust.
— Carlos del Rio (@CarlosdelRio7) January 19, 2021
John Bartlett, M.D., FIDSA, a beloved leader of IDSA, passed away on Jan. 19 at the age of 83. An HIV specialist & leading ID physician, Dr. Bartlett was a trailblazer & empathetic steward of science. He will be deeply missed. #WeAreID
— IDSA (@IDSAInfo) January 19, 2021
Dr. Bartlett's bio: https://t.co/M7Z8XYSCsb pic.twitter.com/8T2KonAaRU
Inside the B.1.1.7 Coronavirus Variant.
— MicrobesInfect (@MicrobesInfect) January 19, 2021
Article summarizes notable mutations in the #B117 lineage of the #SARSCoV2 #coronavirus.https://t.co/sM7FHZRzhG
"The growing menace of bacterial resistance to #antibiotics is one of the most under-reported issues of our time," surgeon warns. https://t.co/aqvjjh22GY
— Save Antibiotics (@saveantibiotics) January 19, 2021
Great paper proposing propose that in #COVID19, absence of both elevated baseline WCC and antibiotic-related decrease in CRP can exclude bacterial co-infection and facilitate #antibioticstewardship efforts: https://t.co/uikrj9HG9n
— BSAC (@BSACandJAC) January 19, 2021
We're delighted that, with the support of @INEOS, @UniofOxford is to open a new research institute to tackle #AntibioticResistance - an indication that the major threat posed by #AMR is starting to attract the much-needed support of high-level investors: https://t.co/IiLJUkhT0X
— BSAC (@BSACandJAC) January 19, 2021
Tonsils removed in surgery are being used by researchers as testbeds for vaccines targeting COVID-19, influenza and other infectious diseases, according to a study published in @NatureMedicine. https://t.co/SaZP6D2yPN
— Stanford Medicine (@StanfordMed) January 19, 2021
Disappointing preliminary data of the BCG-PRIME study lead @MarcBonten "The BCG vaccine does NOT offer vulnerable elderly people protection against #COVID19 @paimadhu https://t.co/mt57yjhuPy
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
Opening certain windows in your car can create air currents that could help keep both riders and drivers safe from infectious diseases like Covid-19, a new study suggests https://t.co/SpnSVGnXOS
— NYT Science (@NYTScience) January 19, 2021
New research Article: Household transmission of #SARSCoV2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study https://t.co/D1ycgQlW5x #COVID19
— The Lancet Infectious Diseases (@TheLancetInfDis) January 19, 2021
Our collaborative research showing that CBD could be the prototypical example of a much-needed new class of antibiotics is now out! See https://t.co/5EMcwwfyxf for the open access paper...#antibiotics #AntimicrobialResistance https://t.co/059ah9RmRz
— Mark Blaskovich (@mark_blaskovich) January 19, 2021
Opening certain windows in your car can create air currents that could help keep both riders and drivers safe from infectious diseases like Covid-19, a new study suggests https://t.co/OZAnLNV6ov
— NYT Health (@NYTHealth) January 19, 2021
Opening certain windows in your car can create air currents that could help keep both riders and drivers safe from infectious diseases like Covid-19, a new study suggests https://t.co/xbyjSRpyms
— NYT Health (@NYTHealth) January 19, 2021
Most Americans say the coronavirus pandemic is out of control, Post-ABC poll finds @washingtonpost Trust me, it is but we can get it under control. It’s not “rocket science” it’s simple public health. https://t.co/OHsRLvRIiq
— Carlos del Rio (@CarlosdelRio7) January 19, 2021
How the field of infectious diseases can leverage digital strategy and social media use during a pandemic https://t.co/ZFXILa1xXO Delighted to publish this paper with members of the @IDSAInfo Digital Strategy Advisory Group. @DrJRMarcelin @Cortes_Penfield @taliaswartz @FungalDoc
— Carlos del Rio (@CarlosdelRio7) January 19, 2021
Oxford given £100m to fight the ‘tsunami’ of antibiotic resistancehttps://t.co/woJNRm86Yc
— Marc Mendelson (@SouthAfricanASP) January 19, 2021
B.1.1.7 has spread far beyond the U.K. and been detected in 20 U.S. states so far, according to @CDCgov. @RoseALeeMD reviews #B117's mutations, the evidence for increased transmissibility and the effect the mutations could have on detection:https://t.co/j8VNMRtzIt #coronoavirus
— ASM (@ASMicrobiology) January 19, 2021
⛔Notice of Retraction ⛔
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
and Replacement. Stefan et al. Association of antibiotic treatment with outcomes in patients hospitalized for an asthma exacerbation treated with systemic corticosteroids
Possible Immortal Time Bias in the Study #IDTwitter https://t.co/sU2Cl3zjzF https://t.co/tgNEprB2xS
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance system target bacteria https://t.co/hTY9Iw5fYg
— Laura Piddock 💙 (@LauraPiddock) January 19, 2021
Important figure @CDCMMWR
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
With vaccination that protects against infection, the early epidemic trajectories do not change and
B.1.1.7 spread still occurs
However, after B.1.1.7 becomes the dominant variant, its transmission was substantially reduced https://t.co/01lc5BoYPr pic.twitter.com/3DejBfpHvZ
Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases & their Metabolic Profiling-Part 2
— Dr. Rajeev K Singla (@RajeevKSingla) January 19, 2021
Free 2 Downloadhttps://t.co/xxglchpfHG@_INPST @AcademicChatter @_atanas_ @indo_journal @DHPSP @ScicommBot @BenthamScienceP @glezdiazh #DHPSP
It was an amazing experience making my small contribution to this paper lead by @taliaswartz!
— Andrej Spec, MD, MSCI (@FungalDoc) January 19, 2021
How the field of infectious diseases can leverage digital strategy and social media use during a pandemic https://t.co/iU9yUVZfQw
Thanks @jhieditor for 50 days' #openaccess to our article on the impact of 'PPE Helpers' in improving PPE knowledge and reducing PPE-related anxiety https://t.co/V4Xzgv20Hx More here https://t.co/Xd7yLeTSK8 #COVID19
— Jon Otter (@jonotter) January 19, 2021
3 versions of the #coronavirus seem to have independently converged on some of the same mutations. The mutations suggest that they confer an evolutionary advantage to the virus. All 3 are becoming more common & are potentially more transmissible.https://t.co/kkpLmpO8Oq
— MicrobesInfect (@MicrobesInfect) January 19, 2021
DECEMBER 2020 ISSUE, CASE REPORT: Bacterial Meningitis Complicated by Venous Sinus Thrombosis: a Case of a Pregnant Woman https://t.co/LbSpguaFwX#idcm #medicaljournal #infectiousdiseases #clinicalmicrobiology #openaccess #Bacterial #meningitis #otitismedia #grampositive pic.twitter.com/889RjBJK1q
— IDCM (@idcmjournal) January 19, 2021
Updated IDSA guidelines 1/18/2021: Treatment and Management of Patients with COVID-19 https://t.co/EKeqRIqX8P pic.twitter.com/EdVj3YwmTT
— Andy Chasteen (@AndyC7798) January 19, 2021
Statements that the AstraZeneca COVID-19 vaccine prevents death “100 per cent of the time” are not based on evidence, according to infectious diseases physicians and statisticians who have closely examined published clinical trial datahttps://t.co/NpxG68Qtlz
— Natasha Robinson (@NC_Robinson) January 19, 2021
Mutations in the HIV-1 envelope glycoprotein can broadly reduce the sensitivity to major classes of antiretrovirals. @mBioJournal https://t.co/Vwo22vk25v pic.twitter.com/ADP7UEHLIS
— ASM (@ASMicrobiology) January 19, 2021
New large study in Lancet Infectious Diseases journal:
— Deirdre Gilhawley (@DeeGilhawley) January 19, 2021
Studied 27,000 households
30,000 confirmed cases & 58,000 close contacts
Found
People 60yrs+ & Infants most likely to get infected
Younger people <20yrs are the most likely to infect others (1.6X)https://t.co/9pF3XBv6T9 https://t.co/GtDnjxm8MF pic.twitter.com/kLulWPZRLn
Read the Alliance response to today's news that @UniofOxford has been given £100m to fight antibiotic resistance by @INEOS 👇https://t.co/w0pBhEcp9G#AMR #oxford #ineos @philip_ciwf pic.twitter.com/pgdzGpKdhj
— Save our Antibiotics (@ASOAntibiotics) January 19, 2021
A Combined Phase 2/3 RCT #CID
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
A 3-day 1 daily dose of 400 µg/kg oral ivermectin was safe and accelerated NS1 antigenemia clearance in dengue patients. However, clinical efficacy of ivermectin was not observed at this dosage regimen#IDTwitter https://t.co/cbakvCKwll
Researchers examine #antibioticresistance patterns in U.S. cases of pediatric typhoid fever. https://t.co/Bo7H9XJvDs
— Save Antibiotics (@saveantibiotics) January 19, 2021
This June, students, academics, industry experts, and policy makers from all across the globe will take part in @mcgillu’s #Online Summer Institute in #infectiousdiseases and #globalhealth. Will you join us? https://t.co/jOAaXEWaAX pic.twitter.com/4kzNjt7vss
— McGill Global Health Programs (@McGillGHP) January 19, 2021
31st European Congress of Clinical #Microbiology & #InfectiousDiseases
— ICOMS (@ICAOMS) January 19, 2021
📅9 - 12 July 2021
🌍Vienna + 💻
💰Students: €49 - €99#TravelGrants for 100 young scientists#ECCMID 21 for '21 #Grant - 21 full online tickets
Abstract Deadline? February 24, 2021 https://t.co/TWfCOXhde6 pic.twitter.com/HzY4OPw3j8
#NCYT
— Uk2day (@growhydrodude1) January 19, 2021
With this newly set up laboratory with a capacity to conduct up to 6,000-8,000 testing per day, total PCR testing capacity, the lab will carry out diagnostics of other infectious diseases such as influenza, tuberculosis, hepatitis B and C virus. https://t.co/6x5hkUCrBy
We are hiring a research coordinator for our exciting international JPIAMR primary care antibiotic audit and feedback network@NoahIvers @GrimshawJeremy @JPIAMR @PublicHealthON https://t.co/TqSW1yPBlC
— Kevin Schwartz (@DrKevinSchwartz) January 19, 2021
“The more data and resources the scientific community can pool, the more it improves the chances of successfully combating existing and new strains of #antibiotic-resistant bacteria,” @pewhealth’s David Hyun, MD, writes. https://t.co/TAZ72JiPoX
— Save Antibiotics (@saveantibiotics) January 19, 2021
It can take up to 2 weeks after the 1st dose of a COVID-19 vaccine to develop a sufficient antibody response, says IDSA spokesperson Gregory Poland, M.D.
— IDSA (@IDSAInfo) January 19, 2021
Stay vigilant with preventative measures before, during & after immunization. #MaskUpAmerica. https://t.co/Fv4ZsLGCl9
Tadesse et al 2021|| - Anopheles stephensi Mosquitoes as Vectors of Plasmodium vivax and falciparum, Horn of Africa, 2019 - Volume 27, Number 2—February 2021 - Emerging Infectious Diseases journal - CDC https://t.co/SdYdMpk91K via @CDCgov
— Fredros Okumu (@Fredros_Inc) January 19, 2021
Health Workers’ Antibody Levels Wane After SARS-CoV-2 Infection | Infectious Diseases | @JAMA_current | @JAMANetworkOpen #covid #coronavirus https://t.co/t9j7NmnYy0
— Neil Floch MD (@NeilFlochMD) January 19, 2021
Sequencing of Wastewater Useful for Control of SARS-CoV-2 - New #COVID19 study in @ASMicrobiology's @mbiojournal https://t.co/G8EjFracvA pic.twitter.com/IKix8s88Zo
— ASM Newsroom (@ASMnewsroom) January 19, 2021
“These smaller hospitals do not have the resources to run an ICU or maintain negative pressure rooms for infectious diseases. What is more, accepting Covid-19 patients puts everything else they do in jeopardy, & so many refuse to treat them.” - @FT 5/4/20https://t.co/OK8LvAGu9o
— Rodney Graves (@rodneyfgraves) January 19, 2021
We are excited to say that Dr Benedict Michael @BenedictNeuro will give the Infectious Diseases Basic science talk titled "Disease Mechanisms in Encephalitis".#theBRAINconference
— Brain (@Brain1878) January 19, 2021
Make sure to not miss out!
Register today: https://t.co/9sgnjKPmvc@bmj_latest @NatureNeuro pic.twitter.com/qCA3SYxlOf
Implementation of an antimicrobial stewardship program in a veterinary medical teaching institution | J Am Vet Med Assoc https://t.co/7XY15UzBoy #AntimicrobialStewardship
— LafeberVet (@LafeberVet) January 19, 2021
Unsure if the article fully reflects the headline but, yes, we need to do everything possible to get kids safely back in school.
— Andrew Morris (@ASPphysician) January 19, 2021
Ontario’s decision to keep students at home questioned by critics. https://t.co/F2Va0bn1hK
📢NEW PUBLICATION📢
— TARGETantibiotics (@TARGETabx) January 19, 2021
Qualitative investigation of the acceptability and feasibility of a #UrinaryTractInfection patient information leaflet for #OlderAdults and #Carers
Read more👉https://t.co/AzpE5lPu1Z
Leaflet👉https://t.co/yCBEwrNZBz#UTI #AntimicrobialStewardship #AMS #AMR pic.twitter.com/6UZnEH5k4D
🍄 Invasive fungal mucormycosis is a scary infection with limited therapeutics
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
NEW 🔥🔥 #IDTwitter @IbrahimLab3
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of Mucormycosis.
Mucrocin toxin is an attractive therapeutic target. https://t.co/r997JsuLcx
California has produced a #coronavirus variant of its own.
— MicrobesInfect (@MicrobesInfect) January 19, 2021
That mutant seemed to have popped up in July but lay low till November.
CAL.20C accounted for > 1/2 of the coronavirus samples collected in Los Angeles labs on Jan. 13, according to new study.https://t.co/C6Iwu0daWb pic.twitter.com/7UUORGVWX8
NEWS SCAN: Coronavirus in ICE facilities; Kids and #COVID19 spread; Waning flu vaccine efficacy #fluvax; H5N1 and H5N8 #AvianFluhttps://t.co/iBSycOtAKq
— CIDRAP (@CIDRAP) January 19, 2021
A2: #HPV affects both males & females. Most new infections are among teens & those in their early 20s. Most who are infected do not have symptoms but can still spread the virus. Learn more: https://t.co/dhUsUX3S7P #SaludTues pic.twitter.com/MtHUdZnvmj
— NFID (@NFIDvaccines) January 19, 2021
I was Dan's section leader during his micro/immunology course in medical school. Since he knew 100X (at least) more than I about immunology, I just let him teach the class. What brainpower. @MGHBWHIDFellows @BarouchLab @BIDMC_IDFellows @bethisraellahey https://t.co/jXfbc2OTh7
— Paul Sax (@PaulSaxMD) January 19, 2021
#AMS Framework developed in https://t.co/pAniup01DY. New: Feasibility & Validity of a Framework for Antimicrobial Stewardship in General Practice: Key Stakeholder Interviews. https://t.co/sowmZ3D0TI @NCAS_Aus @DGPMonash @Danielle_Mazza @JaclynLBishop @KirstyBuising
— Dr Lesley Hawes (@lesleyhawes4) January 19, 2021
attached article is nice. NB my tweet was not fully clear, i should have said if you have a history of unexplained *anaphylaxis* or anaphylaxis to the ingredients ( not just unexplained allergy....) https://t.co/k9wVSOwHNw
— Tammy Rothenberg (@bloggydoc) January 19, 2021
A1: Almost all #CervicalCancer in the US is caused by human papillomavirus or #HPV. HPV is the most common sexually transmitted infection & can also cause other cancers & genital warts. Learn more: https://t.co/dhUsUX3S7P #SaludTues pic.twitter.com/g2riNwjT7N
— NFID (@NFIDvaccines) January 19, 2021
New Institute for Antimicrobial Resistance, addressing the "over-use and mis-use" of antibiotics @UniofOxford https://t.co/3lf7qMMtKh
— Laura Piddock 💙 (@LauraPiddock) January 19, 2021
We're launching a new grant funding opportunity with @CIHR_IRSC (planned Feb 2021) for researchers in Canada to pursue projects advancing CEPI’s work to develop vaccines against emerging infectious diseases, including #COVID19 🇨🇦🌍
— CEPI (@CEPIvaccines) January 19, 2021
More on our website: https://t.co/9xxMUshMVj https://t.co/vtmlbbu9cF
Single Covid vaccine dose in Israel 'less effective than we thought' https://t.co/Ooxepnh4SS
— Laura Piddock 💙 (@LauraPiddock) January 19, 2021
It hurts my ears every time, even reading it.
— Jason Gallagher (@JGPharmD) January 19, 2021
PneumoCystis Pneumonia.
Even these guys said we’re still good with PCPhttps://t.co/cS5ACsK1eF
"For now, the message is clear: “If you’ve recovered from SARS-CoV-2, it’s not an excuse to forget about social distancing and not to wear a mask,” “We know that you can have it twice.” And that means you can get it again and pass it on" @bmj_latest https://t.co/1UvfAs7UtL
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
How did he know?! Any data shared with Pfizer?!
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
Coronavirus czar Nachman Ash says the first dose of Pfizer’s vaccine is turning out to provide less protection against COVID-19 than the US pharmaceutical firm had initially indicated. https://t.co/5Mf4xP4vjU via @timesofisrael
STEWARDSHIP / RESISTANCE SCAN: New Oxford AMR institute; #AntibioticStewardship in an Indian ICU #AMRhttps://t.co/X4wUj5usBa
— CIDRAP (@CIDRAP) January 19, 2021
@immunitybio to begin Phase I trial recruitment is set to begin in February in Cape Town, South Africa as new variants of #SARSCoV2 Spread #immunotherpay #celltherapy #infectiousdiseases #Biotechnology https://t.co/fNyNQJ4FMa pic.twitter.com/EMhXIxo0AU
— ImmunityBio (@immunitybio) January 19, 2021
Another RCT (BRACE-CORONA)
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
that doesn't NOT support routinely discontinuing ACEIs or ARBs in Patients Admitted With #COVID19
https://t.co/fRbFcF4AZO via @JAMA_current part of @JAMANetwork https://t.co/trbZaLOCHE pic.twitter.com/yDR1j9aTLn
California’s top epidemiologist recommends providers pause vaccination from Moderna lot no. 41L20A due to possible allergic reactions
— Tim Lahey, MD, MMSc (@TimLaheyMD) January 19, 2021
—> More evidence of an active and effective real time safety system in place https://t.co/wVVuxTLbkr
"Identifying emerging infectious disease threats in animals before they can spread into human populations may help quash a future outbreak before it begins." https://t.co/YZI0pPPIw8 pic.twitter.com/lXcd7teZrG
— Bulletin of the Atomic Scientists (@BulletinAtomic) January 19, 2021
Puf4 contributes to the intrinsic caspofungin resistance in C. neoformans by post-transcriptional regulation of the FKS1 mRNA. FKS1 encodes the beta-1,3-glucan synthase which is targeted by caspofungin. @mBioJournal https://t.co/V0oaxktwDm pic.twitter.com/fMRDgqWigN
— ASM (@ASMicrobiology) January 19, 2021
She called the doctor to talk about her own autopsy - and then ended her own life
— Tim Lahey, MD, MMSc (@TimLaheyMD) January 19, 2021
Lovely essay & podcast by @TheDoctorIsILL published by @AcadMedJournal
Essay: https://t.co/zJoxMjy2Tq
Podcast: https://t.co/KgK7jlXyvz
#bioethics #MedEd #patholog
The Influenza Vaccines R&D Roadmap posted today is a blueprint for improving seasonal vaccines and developing universal vaccines. The draft roadmap is available for public comment until Feb 12. Feel free to weigh in.#FluVaccinesRoadmaphttps://t.co/lYfbvpR9aj pic.twitter.com/jcYBWy6pzu
— CIDRAP (@CIDRAP) January 19, 2021
Eric Gagnon, Associate Professor at @SIUC & Dr. Krutika Kuppalli, Assistant Professor in the Division of Infectious Diseases at the Medical University of South Carolina discuss #mutations & #vaccines. Read our article to learn the latest from the @CDCgov. https://t.co/bjSpg6IHhR
— Innovation & Tech Today (@InnoTechToday) January 19, 2021
Health Workers’ Antibody Levels Wane After SARS-CoV-2 Infection | Infectious Diseases | JAMA | JAMA Network @JAMANetwork https://t.co/DVNmudeCLE
— Dr. Adnan Khan (Use ❤️ to beat 💔) (@Dr_Khan) January 19, 2021
NEW🔥 @CDCMMWR
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
Sensitivity of the BinaxNOW antigen test, compared with polymerase chain reaction testing, was lower when used to test specimens from asymptomatic (35.8%) than from symptomatic (64.2%) persons, but specificity was high. https://t.co/wrrsunongZ pic.twitter.com/jjQ83qy9nP
"I’ve spent my career as a folklorist studying disease narratives: the rumors, legends, gossip, and jokes that circulate informally during epidemics and pandemics. These narratives are recycled from one epidemic to the next..."https://t.co/sp4JHSL2qQ
— Infectious Diseases (@InfectiousDz) January 19, 2021
Sequencing E. coli isolates from patients with extraintestinal infections (meningitis, pyelonephritis, and peritonitis) finds high mutation rates and suggests strong selective pressure when colonizing these sites. @mSphereJ https://t.co/YzGWEXFdpg pic.twitter.com/j0X9RCmwQD
— ASM (@ASMicrobiology) January 19, 2021
The #COVID19 death toll in the US has passed 400,000.
— MicrobesInfect (@MicrobesInfect) January 19, 2021
Germany tightens its #lockdown rules as a preventive measure against the highly infectious #coronavirus variant that is causing a spike in cases in the UK & elsewhere.https://t.co/GPrRfIIUJP
Using affinity selection and deep sequencing of phage libraries, researchers identify multiple antibody binding sites for norovirus, and show that a relatively small number of sites on the virus bind to a large number of antibodies. https://t.co/pEcOqJlWTj pic.twitter.com/GYFz868im1
— ASM (@ASMicrobiology) January 19, 2021
Hopefully @MarcBonten follows them longer to see the impact of BCG vaccine on cancers https://t.co/6Mdh9PBDTZ
— Eli Perencevich, MD MS🧼 😷 (@eliowa) January 19, 2021
COMMENTARY: From hope to reality: The promise of the Influenza Vaccines R&D Roadmap
— CIDRAP (@CIDRAP) January 19, 2021
Overcoming obstacles to better flu vaccines requires collaboration through innovative approaches on a broad scale, according to @mtosterholm and several other top expertshttps://t.co/25mfSFdS2f pic.twitter.com/kGWpIhNRDq
here is a recent paper from Lancet Infectious Diseases about Ivermectin and Covid-19. Some early promise in reducing some less fatal symptoms even authors suggest bigger studies needed for any definitive conclusions. Boring old research evidence, eh?https://t.co/ana5PWZLo3
— david oliver (@mancunianmedic) January 19, 2021
Yeadon is not an epidemiologist, virologist, or infectious diseases expert, he’s a former drug company employee, not qualified to answer this question. He’s theories have also been widely debunked over and over, like this example https://t.co/THNc3L7YKt
— Tiny Cycle (@tinycycle) January 19, 2021
We identified risk factors for worse outcome in patients with suspected sepsis at the ED. Early risk assessment allows for closer monitoring and better management of patients. #infectiousdiseases #sepsis #emergency #science https://t.co/tUfcBo2ff7 @LCRCenter @JessaZiekenhuis
— Valentino D'Onofrio (@Valentinoooh) January 19, 2021
‘You Really Need That 2nd Dose’: Infectious Disease Specialist Concerned Over 45,000 Overdue For 2nd COVID Shot In Florida https://t.co/39Y6oRWe8k
— Lauren Pastrana CBS4 (@LaurenPastrana) January 19, 2021
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said Monday that the deaths have to be put into context of the population that they occurred in -- a nursing home with extremely frail individuals.https://t.co/2ac54rly4Q
— Tony Leachon MD (@DrTonyLeachon) January 19, 2021
Great article:
— Tim Lahey, MD, MMSc (@TimLaheyMD) January 19, 2021
What the chaos in hospitals is doing to doctors?https://t.co/P6uZCXW9Sj pic.twitter.com/KveHCKbcdj
There's increasing evidence that heterotrophic microeukaryotes are important in marine systems but their diversity & functions are relatively unknown. Scientists report on a major group of unicellular protists in @AppEnvMicro & their role in coastal oceans https://t.co/KuQoVnV5ms pic.twitter.com/iVDkM2X8ow
— ASM (@ASMicrobiology) January 19, 2021
Taurine Enhances the Microbiome’s Resistance to Future Pathogens https://t.co/9vc3kNYzZT via @GENbio #translationalmedicine #omics #infectiousdiseases #microbiome #bacterialdiseases
— Jessi M (@becoming_jessi) January 19, 2021
Did you know infants, the elderly and those with compromised immune systems can’t be vaccinated? Instead, they depend on others to protect them against infectious diseases — called herd immunity — which suffers when not enough people get vaccinated. https://t.co/lGkU2AJBVP pic.twitter.com/bEusM948rk
— BCBSProgress (@BCBSProgress) January 19, 2021
Emergence of SARS-CoV-2 B.1.1.7 Lineage ... https://t.co/7D7NV8eI31 via @CDCgov The increased transmissibility of the B.1.1.7 variant warrants universal and increased compliance with mitigation strategies, including distancing and masking.
— Carlos del Rio (@CarlosdelRio7) January 19, 2021
National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020 | Infectious Diseases | JAMA | JAMA Network https://t.co/9BkOKgSxd0
— K.Nishiumi (@ELSINORE491) January 19, 2021
decades long? like what? seems he got it pretty right for SARS.. bird flu.. swine flu... Zika.. and other infectious diseaseshttps://t.co/ybj6YSS2WY
— Neno (@GuyIncognito_33) January 19, 2021
A positive STI test may indicate a higher risk for hepatitis C virus reinfection among patients with HIV being treated with direct-acting antivirals, study findings published in Open Forum Infectious Diseases suggest.https://t.co/UjPIWdc2tb
— ID News (@InfectDisNews) January 19, 2021
Interesting article & further studies definitely required, age had an effect 🤔...Antimicrobial stewardship is not easy : it continues to be about balance & appropriate antimicrobial prescribing rather than just low antimicrobial prescribing .https://t.co/1E0BXEsVmx
— BernyB (@BernadetteBare8) January 19, 2021
Join us on Wed, Jan 20 at 1:30pm for #Pathology Grand Rounds with Dr. Lieberman, "New and Improving Molecular Tools for Diagnosing Infectious Diseases from Histopathology"
— UW Dept. of Laboratory Medicine and Pathology 🔬 (@uwlabmedpath) January 19, 2021
Details: https://t.co/edR20O9gX4#PathTwitter @MolMicro_Path pic.twitter.com/KbS4mICSwx
Quick read on the great potential of rapid testing as a tool in the workplace to help identify people at their most infectious. from @BogochIsaac and @goldyhyder https://t.co/3tovNxSpm4
— Sumon Chakrabarti (@TorontoIDDoc) January 19, 2021
Such a “me-first approach” left the world’s poorest and most vulnerable at risk, he said
— Peter Collignon (@CollignonPeter) January 19, 2021
Vaccine nationalism puts world on brink of 'catastrophic moral failure': WHO chief https://t.co/DtU4KjjWcy
Yes! Our qualitative and quantitative data showed this as well. This led us to develop our new website: https://t.co/zsyqblsYVm. Check it out! https://t.co/GDGN8w9924 #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) January 19, 2021
✨Looking beyond COVID-19 vaccine phase 3 trials✨ #COVID19 @NatureMedicinehttps://t.co/Hi17Lt18Y1 pic.twitter.com/iohvagDRjG
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
"The world is on the edge of a “catastrophic moral failure” in the distribution of Covid-19 vaccines, with just 25 doses administered across all poor countries compared with 39m in wealthier ones" @DrTedros https://t.co/dUiCAwX2hZ
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) January 19, 2021
Flu vaccine roadmap aims to promote game-changers, equity
— CIDRAP (@CIDRAP) January 19, 2021
Truly revolutionary flu vaccines and equitable distribution are key goals of a remarkable group of influenza experts convened by CIDRAPhttps://t.co/dbC3iH2WI3 pic.twitter.com/a3s6s84YMp
Most Americans want vaccine as nation tops 400,000 #COVID19 deaths
— CIDRAP (@CIDRAP) January 19, 2021
And more than 60% of Americans prioritize public health over the economy in new poll...https://t.co/iZYpf7iD6l pic.twitter.com/qP9YH701qD
“I did it to enjoy life.”
— EC in Cyprus (@EUCYPRUS) January 19, 2021
Dr. Charles Mallia Azzopardi,
Consultant in Infectious Diseases and Internal Medicine,
Chief Coronavirus Adviser, Malta 🇲🇹https://t.co/g1UnTmmQU9#GetTheVaccine pic.twitter.com/r2T0KEc2wa
New CDC director Rochelle Walensky, in an interview with @betswrites, pledged to speed vaccination and restore public trust in the agency. She was previously chief of infectious diseases at Massachusetts General Hospital in Boston https://t.co/6PYSZomdlT via @wsj
— JamesVGrimaldi (@JamesVGrimaldi) January 19, 2021
Professor Marc Mendelson, the head of UCT’s Division of Infectious Diseases and HIV Medicine at Groote Schuur Hospital, recently delivered a Summer School lecture on COVID-19. Read more: https://t.co/EjWQpazVJq pic.twitter.com/R6W0jHccBk
— UCT (@UCT_news) January 19, 2021
Created by Cameron Forbes. Last updated January 20, 2021 at 05:17 EST.